Pharos iBio Co., Ltd. (KOSDAQ:388870)
9,350.00
+70.00 (0.75%)
At close: Apr 28, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 121.04 billion as of April 29, 2026. Its market cap has increased by 50.81% in one year.
Market Cap
121.04B
Enterprise Value
102.98B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,350.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has increased from 112.78B to 121.04B, an increase of 7.33%. That is a compound annual growth rate of 2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 120.14B | -1.17% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 120.80B |
| KOREA PHARMA | 128.59B |
| HYUNDAI BIOLAND | 133.50B |
| H.PIO | 105.87B |
| DongKoo Bio & Pharma | 139.81B |
| Cosmax Nbt | 101.34B |
| Daehan Nupharm | 99.79B |
| PHARMARESEARCH BIO | 144.65B |